[1] Barnes L,Eveson J W,Reichart P A,et al.World Health OrganizationClassification of Tumors :pathology and genetics of head and necktumors [M].Lyon IARC,2005:306-307[2]胡永杰,李思毅,徐立群,等.减压术治疗下颌骨大型牙源性角化囊肿的临床研究[J].中国口腔颌面外科杂志,2005,3(4):299-302[3]Tabrizi R,?zkan BT,et al.Marsupialization as a treatment option for theodontogenickeratocyst[J].J Craniofac Surg,2012,23(5):e459-461[4]Chong HuatSiar,Hitoshi Nagatsuka,PhuuPwint Han,et al.Differentialexpression of canonical and non-canonical Wnt ligandsin ameloblastoma[J].J Oral Pathol Med,2012,41(4):332-339[5]Hakim SG,Kosmehl H,Sieg P,et al.Altered expression of cell-celladhesion molecules β-catenin/E-cadherin and related Wnt-signalingpathway in sporadic and syndromalkeratocysticodontogenictumors[J].Clin Oral Investig,2011,15(3):321-328[6]孔丽,王炳超,袁荣涛,贾暮云,王科.Wnt信号通路相关基因在颌骨牙源性角化囊性瘤中的表达及意义[J].上海口腔医学,2015,01:89-93[7]Kim J,Zhang X,Rieger-Christ KM,et al.Suppression of Wntsignaling by the green tea compound (-)-epigallocatechin 3-gallate(EGCG) in invasive breast cancer cellsRequirement of thetranscriptional repressor HBP1[J]..Biol Chem,2006,281(16):10865-10875[8]Zhao YF,Wei JX,Wang SP,et al.Treatment of odontogenickeratocysts :A follow-up of 225 Chinese patients[J].Oral Surg Oral Med Oral Pthol Oral Radiol Endod,2002,94(2):151-156[9]Johnson NR,Batstone MD,Savage NW.Management and recurrenceof keratocysticodontogenic tumor: a systematic review[J].Oral Surg OralMed Oral Pathol Oral Radiol,2013,116(4):e271-276[10]Güler N,Sen?ift K,et al.Conservative manage- ment ofkeratocysticodontogenic tumors of jaws[J].Scientific World Journal,2012,2012:680397-[11]辛俊彤,袁荣涛,卜令学,等.开窗减压术治疗颌骨巨大囊性病变的临床研究[J].口腔医学,2011,31(4):228-230[12]Pogrel MA,Jordan RC.Marsupialization as a definitive treatment forthe odontogenickeratocyst[J].Oral Maxillofac Surg,2004,62(6):651-656[13]Hj?rting-Hansen E,Schou S,Worsaae N.Suction drainage in thepostsurgical treatment of jaw cysts[J].Oral Maxillofac Surg,1993,51(6):630-633[14]蒋自强,赵怡芳.负压吸引术和减压术治疗牙源性角化囊肿的对比研究[J].华西口腔医学杂志,2002,20(4):265-267[15]Pourreyron C,Reilly L,Proby C,et al.Wnt5a is strongly expressedat the leading edge in non-melanoma skin cancer,forming activegradients,while canonical Wntsignalling is repressed[J].PLoS One,2012,7(2):e31827-[16]Caldwell GM,Jones CE,Ashley AM,et al.Wntsignalling inadenomas of familial adenomatous polyposis patients[J].Br J Cancer,2010,103(6):910-917[17]Tao L,Park JY,et al.Differentialprooxidativeeffects ofthegreen teapolyphenol,(-)-epigallocatechin-3-gallate,in normal and oralcancer cells arerelated todifferences in sirtuin 3 signaling[J].MolNutr Food Res,2015,59(2):203-211[18]Zhu BH,Chen HY,Zhan WH,et al.(-)-Epigallocatechin-3-gallateInhibitsVEGF expression induced by IL-6 via Stat3 in gastric cancer[J].World J Gastroenterol,2011,17(18):2315-2325[19]Wang P,Henning SM,Heber D,et al.Sensitizationto docetaxel in prostate cancer cells by green tea and quercetin[J].J Nutr Biochem,2015,26(4):408-415[20]Dryden GW,Lam A,Beatty K,et al.A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis[J].Inflamm Bowel Dis,2013,19(9):1904-1912 |